SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

U.S. Food and Drug Administration at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

U.S. Food and Drug Administration brings 3 presentations to SITC 2026 in Phoenix. Its program centres on how regulators view new cancer immunotherapies, from safety testing methods to the use of AI in biomarker discovery. One concrete item examines whether biological sex affects key quality measures of CAR T cell products.

OrganizationSITC 2026 Attendance
Government & non-profit
U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies.
Session
Wed Nov 4
2:10pm–2:55pm
Session
Wed Nov 4
3:10pm–3:55pm
Panel Discussion 2: Biomarker Discovery and Digital AI
Biomarkers · AI & data
Session
Wed Nov 4
4:10pm–4:55pm
Panel Discussion 3: Regulatory Framework for New IO Agents
Regulatory · New agents
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at U.S. Food and Drug Administration

Tell us what you sell and we’ll find the people at U.S. Food and Drug Administration most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction